← Leaderboards
Ronald Hoffman
Rush University Medical Center
$16,556,136
Attributed
$16,606,134
Total exposure
13
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.8M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$90,370,078 · 14
By mechanism
P01$87,546,631 · 11
R01$2,723,450 · 2
R56$99,997 · 1
Top collaborators
- Yelena Ginzburg1 shared
Others in their field
Top investigators on “Hematopoietic Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$222,127,419
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$80,540,126
- David T Scadden · Massachusetts General Hospital$40,987,034
- David A Williams · Indiana Univ-Purdue Univ At Indianapolis$36,503,708
- Irving Lerner Weissman · Stanford University$36,281,548
- Bruce R. Blazar · University Of Minnesota$33,175,355
Research focus
Hematopoietic Stem CellsClinical TrialsPharmaceutical PreparationsMyeloproliferative DiseaseStem CellsCellsFoundationsInstitutionResearch PersonnelSignal TransductionMalignant - DescriptorMyelofibrosisFundingSiteCytokineEvolutionMarrowDisease ProgressionPolycythemia VeraEventMonitorCharacteristicsHemorrhagic ThrombocythemiaHematopoiesis
Grant awards (60)
Myeloproliferative Neoplasms-Research Consortium$3,957,858
P01 · FY2025 · CA · contact PI
Core A: Administrative Core$474,327
P01 · FY2025 · CA · contact PI
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells$462,546
P01 · FY2025 · CA · contact PI
Myeloproliferative Neoplasms-Research Consortium$3,861,949
P01 · FY2024 · CA · contact PI
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells$542,504
P01 · FY2024 · CA · contact PI
Core A: Administrative Core$450,611
P01 · FY2024 · CA · contact PI
Myeloproliferative Neoplasms-Research Consortium$4,114,819
P01 · FY2023 · CA · contact PI
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells$481,550
P01 · FY2023 · CA · contact PI
Core A: Administrative Core$474,327
P01 · FY2023 · CA · contact PI
MPN Research Consortium$3,669,084
P01 · FY2022 · CA · contact PI
Core A: Administrative Core$357,312
P01 · FY2022 · CA · contact PI
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells$335,170
P01 · FY2022 · CA · contact PI
Mechanistic understanding of dysregulated iron metabolism in polycythemia vera$99,997
R56 · FY2022 · DK
MPN Research Consortium$3,737,982
P01 · FY2021 · CA · contact PI
Core A: Administrative Core$364,605
P01 · FY2021 · CA · contact PI
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells$342,008
P01 · FY2021 · CA · contact PI
MPN Research Consortium$3,805,296
P01 · FY2020 · CA · contact PI
Core A: Administrative Core$364,605
P01 · FY2020 · CA · contact PI
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells$342,009
P01 · FY2020 · CA · contact PI
MPN Research Consortium$3,691,197
P01 · FY2019 · CA · contact PI
Core A: Administrative Core$353,667
P01 · FY2019 · CA · contact PI
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells$331,748
P01 · FY2019 · CA · contact PI
MPN Research Consortium$3,937,342
P01 · FY2018 · CA · contact PI
Core A: Administrative Core$402,371
P01 · FY2018 · CA · contact PI
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells$342,009
P01 · FY2018 · CA · contact PI
MPD Research Consortium$6,480,908
P01 · FY2015 · CA · contact PI
Administration Core$760,605
P01 · FY2015 · CA · contact PI
Abnormal Stem Cell Trafficking in IM$557,056
P01 · FY2015 · CA · contact PI
MPD Research Consortium$3,221,226
P01 · FY2014 · CA · contact PI
Administration Core$379,235
P01 · FY2014 · CA · contact PI
Abnormal Stem Cell Trafficking in IM$322,541
P01 · FY2014 · CA · contact PI
MPD Research Consortium$3,842,401
P01 · FY2013 · CA · contact PI
Administration Core$533,697
P01 · FY2013 · CA · contact PI
Abnormal Stem Cell Trafficking in IM$387,921
P01 · FY2013 · CA · contact PI
MPD Research Consortium$5,036,436
P01 · FY2012 · CA · contact PI
Administration Core$573,794
P01 · FY2012 · CA · contact PI
Abnormal Stem Cell Trafficking in IM$430,631
P01 · FY2012 · CA · contact PI
MPD Research Consortium$5,185,968
P01 · FY2011 · CA · contact PI
Administration Core$540,109
P01 · FY2011 · CA · contact PI
Abnormal Stem Cell Trafficking in IM$399,509
P01 · FY2011 · CA · contact PI
MYELOPROLIFERATIVE DISORDERS RESEARCH CONSORTIUM$4,738,076
P01 · FY2009 · CA · contact PI
Abnormal Stem Cell Trafficking in IM$261,398
P01 · FY2009 · CA · contact PI
MYELOPROLIFERATIVE DISORDERS RESEARCH CONSORTIUM$4,612,519
P01 · FY2008 · CA · contact PI
Abnormal Stem Cell Trafficking in IM$260,602
P01 · FY2008 · CA · contact PI
MYELOPROLIFERATIVE DISORDERS RESEARCH CONSORTIUM$4,870,883
P01 · FY2007 · CA · contact PI
Adminstrative Core$361,356
P01 · FY2007 · CA · contact PI
Abnormal Stem Cell Trafficking in IM$213,345
P01 · FY2007 · CA · contact PI
MPD RESEARCH CONSORTIUM$5,000,000
P01 · FY2006 · CA · contact PI
Administrative Core$316,910
P01 · FY2006 · CA · contact PI
Abnormal Stem Cell Trafficking in IM$193,515
P01 · FY2006 · CA · contact PI
Hematopoietic Potential of Skeletal Muscle Cells$389,675
R01 · FY2004 · HL
Hematopoietic Potential of Skeletal Muscle Cells$389,675
R01 · FY2003 · HL
Hematopoietic Potential of Skeletal Muscle Cells$389,675
R01 · FY2002 · HL
ALLOCHIMERISM FOLLOWING HAPLOIDENTICAL STEM CELL TRANSPL$388,250
R01 · FY2002 · HL
CORE--CELL SORTING$312,755
P01 · FY2002 · CA
Hematopoietic Potential of Skeletal Muscle Cells$389,675
R01 · FY2001 · HL
ALLOCHIMERISM FOLLOWING HAPLOIDENTICAL STEM CELL TRANSPL$388,250
R01 · FY2001 · HL
CORE--CELL SORTING$312,755
P01 · FY2001 · CA
ALLOCHIMERISM FOLLOWING HAPLOIDENTICAL STEM CELL TRANSPL$388,250
R01 · FY2000 · HL
CORE--CELL SORTING$243,584
P01 · FY2000 · CA